Disopyramide vs placebo or no treatment
All‐cause mortality · adults in sinus rhythm after cardioversion of atrial fibrillation
It is very uncertain whether disopyramide changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
- Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation 2019 · Cochrane Headline outcomes onlyRR 5 [0.25, 101.37]1 study · 92 participantsVery low